What is the role of sublingual glyceryl trinitrate (GTN) in treating a patient with unstable angina or non‑ST‑segment elevation myocardial infarction presenting with chest pain?

Role of Sublingual GTN in UA/NSTEMI

Sublingual or spray nitroglycerin (GTN) should be given to all patients with unstable angina or NSTEMI for immediate symptom relief and prophylactic use, with specific instructions: take 1 dose (0.4 mg) at onset of chest pain, and if pain is unimproved or worsening after 5 minutes, call 9-1-1 immediately before taking additional doses. 1, 2, 3

Immediate Symptom Management

Acute Presentation

• Initial dose: 0.4 mg sublingual GTN every 5 minutes for up to 3 total doses while assessing need for IV nitroglycerin 1, 4
• Purpose: Immediate relief of ongoing ischemic chest pain 5
• Administer while patient is sitting or lying down to prevent hypotension-related falls 5

Critical Safety Parameters

GTN is contraindicated when 1:

• Systolic BP <90 mmHg or ≥30 mmHg below baseline
• Heart rate <50 or >100 bpm (without symptomatic heart failure)
• Phosphodiesterase inhibitor use within 24 hours (sildenafil) or 48 hours (tadalafil)
• Right ventricular infarction
• Soluble guanylate cyclase stimulator use 5

Patient Education Protocol

For Previously Prescribed GTN Users

Modified "call first" approach 6:

1. Take 1 GTN dose immediately when chest pain begins
2. If pain unimproved or worsening at 5 minutes → Call 9-1-1 FIRST
3. While awaiting EMS, may take additional doses every 5 minutes (maximum 3 total doses) while sitting/lying down 1, 2

This represents a critical change from traditional recommendations that advised taking 3 doses before calling emergency services—the modification encourages earlier EMS activation to reduce dangerous delays 6.

For Chronic Stable Angina Patients

If symptoms significantly improve after 1 dose, may repeat every 5 minutes for maximum 3 doses, but call 9-1-1 if symptoms don't completely resolve 6.

Prophylactic Use

• Take 5-10 minutes before activities expected to precipitate angina 2, 5
• 74% effective for prophylaxis vs 66% for sublingual formulation in one study 7

Discharge Instructions (Class I Recommendations)

All post-UA/NSTEMI patients must receive 1, 2, 3:

• Sublingual or spray GTN prescription
• Written and verbal instructions on proper use
• Education on when to seek emergency care
• Instructions that anginal discomfort lasting >2-3 minutes should prompt discontinuation of activity and GTN use

Transition to IV Nitroglycerin

Consider IV GTN for 1, 4:

• Persistent ischemia despite sublingual doses
• Heart failure
• Hypertension
• First 48 hours after UA/NSTEMI with ongoing symptoms

Important caveat: The decision to use IV GTN should not delay other mortality-reducing interventions like beta-blockers or ACE inhibitors 1.

Common Pitfalls to Avoid

1. Self-medication delays: Patients attempting multiple GTN doses before calling EMS is a documented cause of dangerous delays in ACS patients 6
2. Storage issues: >40% of patients transfer tablets to inappropriate containers, reducing potency 8
3. Tolerance development: Excessive use can lead to tolerance; use smallest effective dose 5
4. Hypotension risk: Particularly in volume-depleted patients or those already hypotensive 5
5. Drug interactions: Concomitant alcohol use may cause hypotension; aspirin may enhance vasodilatory effects 5

Clinical Context

While GTN provides symptomatic relief, it has no proven mortality benefit in acute MI or heart failure 5. The primary value is immediate symptom management and as a bridge to definitive therapy. The emphasis on early EMS activation (at 5 minutes rather than after 3 doses) reflects recognition that self-medication can dangerously delay access to life-saving interventions like antiplatelet therapy, anticoagulation, and revascularization.

Key teaching point: GTN's burning/tingling sensation under the tongue should not be relied upon to assess tablet potency 5.